Do-Youn Oh

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Do-Youn Oh
Nov 25, 2024, 12:34 | Drugs
Aakash Desai: FDA approves a biparatopic, Zanidatamab - targeting HER2 for BTCs
Aakash Desai, Associate Director and Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared a post…
Nov 24, 2024, 07:52 | Drugs
U.S. FDA Approval of Ziihera for the Previously Treated, Unresectable or IHC 3+ Biliary Tract Cancer
Ziihera is a targeted treatment used to treat HER2-positive biliary tract cancer (BTC) that has already been…
Sep 5, 2024, 19:32 | Insight
Francisco Esteva: HER2-targeted therapies are being explored for various other solid tumors
Francisco Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Jul 25, 2024, 07:47 | Insight
HER2-targeted therapies beyond breast cancer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X about a…
Jul 25, 2024, 01:39 | Insight
An update on the development of HER2-targeted therapies
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: "HER2-targeted therapies…
Jul 23, 2024, 08:25 | Blog
Paolo Tarantino: HER2: a remarkable story of precision oncology
Paolo Tarantino shared on X: "HER2: a remarkable story of precision oncology. Check this wonderful Nature…
Jul 3, 2024, 05:47 | Societies
Keynote lecture on liver cancer by Stephen L Chan
Lorenza Rimassa, Associate Professor of Medical Oncology at HUNIMED, shared on X: "Ready for the…
Jun 18, 2024, 07:07 | Insight
Tislelizumab plus chemotherapy in advanced gastric/GEJ adenocarcinoma
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Tislelizumab plus chemotherapy vs…
All: 8 Posts: 1 - 100
Special Coverage